Enterprises of the Belbiopharm concern have increased exports by almost 60% in 4 years

April 8, Vitebsk / Sergey Kochetov - BELTA /. In 2006-2009, enterprises of the "Belbiopharm" concern increased their product exports by almost 60% to $73.2 million. This was announced by First Deputy Chairman of the "Belbiopharm" concern Vladimir Gapanovich at the VIII Congress of Pharmacists of Belarus, which is taking place today in Vitebsk, BELTA correspondent reports. The main export market for the concern's pharmaceutical enterprises is Russia. In 2009, medicines worth over $39 million, or more than 53% of the total supply volume, were delivered to the Russian market, with an increase of more than $5 million. In total, the concern's enterprises export products to 21 countries worldwide. Over the past three years, the geography of supplies has expanded due to the development of markets in Bulgaria, Afghanistan, Mongolia, the USA, Hungary, and Great Britain. In 2009, over 110 registration certificates for the concern's enterprises' products were obtained abroad. -0-